 |
Ammonium trichloro [dioxoethylene-O,O’) tellurium (IV) |
|---|---|
| Trade Name | |
| Orphan Indication | Acquired immunodeficiency syndrome |
| USA Market Approval | USA |
| USA Designation Date | 1987-11-09 00:00:00 |
| Sponsor | NPDC-AS101, Inc.;783 Jersey Avenue;New Brunswick, New Jersey, 08901 |
